On Sunday, U.S. President Donald Trump changed that precedent, announcing that he would sign an executive order Monday to ...

Shares of pharmaceutical companies dropped early Monday after President Donald Trump said he would lower the cost of ...

Merck Animal Health will invest $895 million to expand vaccine manufacturing and R&D in Kansas, while Lilly is committing ...

Merck & Co., Inc. (MRK) is currently at $79.17, up $3.20 or 4.21% --On pace for largest percent increase since March 27, 2024, when it rose 4.96% --Down 40.46% from its all-time closing high of ...

Halozyme Therapeutics posts strong Q1 2025 earnings with 35% revenue growth, robust pipeline, and rising royalties.

Under this new initiative, the US government will give pharmaceutical companies specific price targets to meet within the ...

A list of high-quality dividend-growth stocks trading near 52-week lows is evaluated. Read what makes GOOG stock is a ...

President Donald Trump says he’ll sign an executive order on Monday intended to lower the cost of drugs in the U.S.

A combination of the HER2 agent, called disitamab vedotin, and Junshi Biosciences’ PD-1 inhibitor toripalimab outperformed ...

President Trump plans to sign an executive order mandating drugmakers to align U.S. drug prices with those of other countries ...

Big gains for Wall Street, along with other global stock markets including the TSX today on news the Trump administration is pausing tariffs with China ahead of a new trade deal.

Shares of Alphamab Oncology plunged 14.4% to HK$6.28, leading declines in Hong Kong-listed pharmaceutical stocks.Meanwhile, ...